Substance use Reference Group
Development of this web resource and the associated yarning place is guided by a national reference group. The Substance Use Reference Group, comprising Indigenous and non-Indigenous people working as practitioners, policy-makers and/or researchers in the area of substance use among Indigenous peoples, provides advice on:
- content of the web resources, including the co-opting of people for expert advice;
- priorities for future development of content areas;
- promotion of the resource and of the HealthInfoNet's work among people and organisations involved in areas that address the harmful use of substance among Indigenous peoples. This includes the development and enhancement of linkages with relevant organisations/agencies. They will also look at aspects of the associated 'yarning places' - electronic networks based on the ‘community of practice' (CoP) model - in their area(s) of interest (including how to promote their use, providing contact details for potential members, etc);
- appointment of HealthInfoNet Consultants in the area of the use of alcohol and other drugs among Indigenous peoples.
Members of the Substance Use Reference Group are:
|Last Name||First Name||Organisation||State|
|Casey||Wendy||Aboriginal Alcohol and other Drugs Program, Western Australia Drug and Alcohol Office||WA|
|Clough||Alan||School of Public Health, Tropical Medicine & Rehabilitation Sciences and School of Indigenous Australian Studies, James Cook University||QLD|
|Conigrave||Kate||Drug Health Services, Royal Prince Alfred Hospital||NSW|
|Gray||Dennis||National Drug Research Institute, Curtin University of Technology||WA|
|Hayman||Noel||Inala Community Health Centre||QLD|
|Wilson||Scott||The Aboriginal Drug and Alcohol Council (SA) Inc (ADAC)||SA|
The reference group meetings also involve the HealthInfoNet's research/project officers working on the development of the resources on substance use, and a representative of the Alcohol and Indigenous Programs Section of the Australian Department of Health and Ageing's Drug Strategy Branch.